Huxley-Jones J, Clarke TK, Beck C, Toubaris G, et al: 'The evolution of the vertebrate metzincins; insights from Ciona intestinalis and Danio rerio'. BMC Evol Biol. 2007, 7: 63-10.1186/1471-2148-7-63.
Article
PubMed Central
PubMed
Google Scholar
Cauwe B, Van den Steen PE, Opdenakker G: 'The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases'. Crit Rev Biochem Mol Biol. 2007, 42: 113-185. 10.1080/10409230701340019.
Article
CAS
PubMed
Google Scholar
Gross J, Lapiere CM: 'Collagenolytic activity in amphibian tissues: A tissue culture assay'. Proc Natl Acad Sci USA. 1962, 48: 1014-1022. 10.1073/pnas.48.6.1014.
Article
PubMed Central
CAS
PubMed
Google Scholar
Nagase H, Barrett AJ, Woessner JF: 'Nomenclature and glossary of the matrix metalloproteinases'. Matrix Suppl. 1992, 1: 421-424.
CAS
PubMed
Google Scholar
Sternlicht MD, Werb Z: 'How matrix metalloproteinases regulate cell behavior'. Annu Rev Cell Dev Biol. 2001, 17: 463-516. 10.1146/annurev.cellbio.17.1.463.
Article
PubMed Central
CAS
PubMed
Google Scholar
Visse R, Nagase H: 'Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function, and biochemistry'. Circ Res. 2003, 92: 827-839. 10.1161/01.RES.0000070112.80711.3D.
Article
CAS
PubMed
Google Scholar
Le NT, Xue M, Castelnoble LA, Jackson CJ: 'The dual personalities of matrix metalloproteinases in inflammation'. Front Biosci. 2007, 12: 1475-1487. 10.2741/2161.
Article
CAS
PubMed
Google Scholar
Nagase H, Visse R, Murphy G: 'Structure and function of matrix metalloproteinases and TIMPs'. Cardiovasc Res. 2006, 69: 562-573. 10.1016/j.cardiores.2005.12.002.
Article
CAS
PubMed
Google Scholar
Van Wart HE, Birkedal-Hansen H: 'The cysteine switch: A principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family'. Proc Natl Acad Sci USA. 1990, 87: 5578-5582. 10.1073/pnas.87.14.5578.
Article
PubMed Central
CAS
PubMed
Google Scholar
Piccard H, Van den Steen PE, Opdenakker G: 'Hemopexin domains as multifunctional liganding modules in matrix metalloproteinases and other proteins'. J Leukoc Biol. 2007, 81: 870-892. 10.1189/jlb.1006629.
Article
CAS
PubMed
Google Scholar
Fernandez-Patron C, Zouki C, Whittal R, Cwan JS, et al: 'Matrix metalloproteinases regulate neutrophil-endothelial cell adhesion through generation of endothelin-1[1-32]'. FASEB J. 2001, 15: 2230-2240. 10.1096/fj.01-0178com.
Article
CAS
PubMed
Google Scholar
Banda MJ, Rice AG, Griffin GL, Senior RM: 'Alpha 1-proteinase inhibitor is a neutrophil chemoattractant after proteolytic inactivation by macrophage elastase'. J Biol Chem. 1988, 263: 4481-4484.
CAS
PubMed
Google Scholar
Gearing AJ, Beckett P, Christodoulou M, Churchill M, et al: 'Processing of tumour necrosis factor-alpha precursor by metalloproteinases'. Nature. 1994, 370: 555-557. 10.1038/370555a0.
Article
CAS
PubMed
Google Scholar
Gearing AJ, Beckett P, Christodoulou M, Churchill M, et al: 'Matrix metalloproteinases and processing of pro-TNF-alpha'. J Leukoc Biol. 1995, 57: 774-777.
CAS
PubMed
Google Scholar
Ito A, Mukaiyama A, Itoh Y, Nagase H, et al: 'Degradation of interleukin 1beta by matrix metalloproteinases'. J Biol Chem. 1996, 271: 14657-14660. 10.1074/jbc.271.25.14657.
Article
CAS
PubMed
Google Scholar
Yu Q, Stamenkovic I: 'Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis'. Genes Dev. 2000, 14: 163-176.
PubMed Central
PubMed
Google Scholar
Schultz GS, Wysocki A: 'Interactions between extracellular matrix and growth factors in wound healing'. Wound Repair Regen. 2009, 17: 153-162. 10.1111/j.1524-475X.2009.00466.x.
Article
PubMed
Google Scholar
Pei D, Weiss SJ: 'Furin-dependent intracellular activation of the human stromelysin-3 zymogen'. Nature. 1995, 375: 244-247. 10.1038/375244a0.
Article
CAS
PubMed
Google Scholar
Massova I, Kotra LP, Fridman R, Mobashery S: 'Matrix metalloproteinases: Structures, evolution, and diversification'. FASEB J. 1998, 12: 1075-1095.
CAS
PubMed
Google Scholar
Fingleton B: 'Matrix metalloproteinases as valid clinical targets'. Curr Pharm Des. 2007, 13: 333-346. 10.2174/138161207779313551.
Article
CAS
PubMed
Google Scholar
Gruber BL, Sorbi D, French DL, Marchese MJ, et al: 'Markedly elevated serum MMP-9 (gelatinase B) levels in rheumatoid arthritis: A potentially useful laboratory marker'. Clin Immunol Immunopathol. 1996, 78: 161-171. 10.1006/clin.1996.0025.
Article
CAS
PubMed
Google Scholar
Itoh T, Matsuda H, Tanioka M, Kuwabara K, et al: 'The role of matrix metalloproteinase-2 and matrix metalloproteinase-9 in antibody-induced arthritis'. J Immunol. 2002, 169: 2643-2647.
Article
CAS
PubMed
Google Scholar
Toriseva M, Kahari VM: 'Proteinases in cutaneous wound healing'. Cell Mol Life Sci. 2009, 66: 203-224. 10.1007/s00018-008-8388-4.
Article
CAS
PubMed
Google Scholar
Daheshia M: 'Therapeutic inhibition of matrix metalloproteinases for the treatment of chronic obstructive pulmonary disease (COPD)'. Curr Med Res Opin. 2005, 21: 587-594. 10.1185/030079905X41417.
Article
CAS
PubMed
Google Scholar
Lagente V, Manoury B, Nenan S, Le Quement C, et al: 'Role of matrix metalloproteinases in the development of airway inflammation and remodeling'. Braz J Med Biol Res. 2005, 38: 1521-1530. 10.1590/S0100-879X2005001000009.
Article
CAS
PubMed
Google Scholar
Hautamaki RD, Kobayashi DK, Senior RM, Swapiro SD: 'Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice'. Science. 1997, 277: 2002-2004. 10.1126/science.277.5334.2002.
Article
CAS
PubMed
Google Scholar
McCawley LJ, Matrisian LM: 'Matrix metalloproteinases: Multifunctional contributors to tumor progression'. Mol Med Today. 2000, 6: 149-156. 10.1016/S1357-4310(00)01686-5.
Article
CAS
PubMed
Google Scholar
Philip M, Rowley DA, Schreiber H: 'Inflammation as a tumor promoter in cancer induction'. Semin Cancer Biol. 2004, 14: 433-439. 10.1016/j.semcancer.2004.06.006.
Article
CAS
PubMed
Google Scholar
Coussens LM, Fingleton B, Matrisian LM: 'Matrix metalloproteinase inhibitors and cancer: Trials and tribulations'. Science. 2002, 295: 2387-2392. 10.1126/science.1067100.
Article
CAS
PubMed
Google Scholar
Pavlaki M, Zucker S: 'Matrix metalloproteinase inhibitors (MMPIs): The beginning of phase I or the termination of phase III clinical trials'. Cancer Metastasis Rev. 2003, 22: 177-203. 10.1023/A:1023047431869.
Article
CAS
PubMed
Google Scholar
Rosenberg GA: 'Matrix metalloproteinases and their multiple roles in neurodegenerative diseases'. Lancet Neurol. 2009, 8: 205-216. 10.1016/S1474-4422(09)70016-X.
Article
CAS
PubMed
Google Scholar
Yin KJ, Cirrito JR, Yan P, Hu X, et al: 'Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-beta peptide catabolism'. J Neurosci. 2006, 26: 10939-10948. 10.1523/JNEUROSCI.2085-06.2006.
Article
CAS
PubMed
Google Scholar
Choi DH, Kim EM, Son HJ, Joh TH, et al: 'A novel intracellular role of matrix metalloproteinase-3 during apoptosis of dopaminergic cells'. J Neurochem. 2008, 106: 405-415. 10.1111/j.1471-4159.2008.05399.x.
Article
CAS
PubMed
Google Scholar